In the latest installment of the Morgan Lewis M&A Academy, partners Laurie Burlingame and Luciana Griebel provided an overview of current market trends in mergers and acquisitions (M&A) and strategic partnerships within the life sciences sector. While a few multi-billion-dollar deals stood out in 2024, the pace of large life sciences transactions slowed considerably. While 2025 was off to a promising start—with four billion-dollar deals announced on the first day of the J.P. Morgan Healthcare Conference in January—the overall pace of M&A deals over the first quarter of 2025 was slower than many anticipated.
Read the full article: M&A Considerations Across the Evolving Life Sciences Sector: Key Takeaways //
Source: https://www.lexology.com/library/detail.aspx?g=4a95248c-fa57-40ef-a70f-d6afed807aa4